Literature DB >> 1644329

Interferon-alpha (IFN-alpha) production by human intestinal mononuclear cells. Response to virus in control subjects and in Crohn's disease.

M R Capobianchi1, S Fais, F Mercuri, M Boirivant, F Dianzani, F Pallone.   

Abstract

The virus induced production of interferon alpha by human intestinal lamina propria mononuclear cells was investigated. Intestinal and autologous peripheral cells from control subjects and patients with Crohn's disease were cultured in vitro with and without stimulation with the Newcastle disease virus. Interferon alpha was measured and characterised in the culture supernatants after 12 hours and the kinetics of production was evaluated over the following four days of culture. No detectable interferon alpha was found in cultures of unstimulated intestinal and autologous peripheral mononuclear cells from controls and Crohn's disease whereas interferon alpha was released in all cultures stimulated with the virus. In all 12 hours experiments in both groups, virus stimulated intestinal mononuclear cells yielded significantly less interferon alpha than the autologous peripheral cells. The kinetics experiments showed that control intestinal mononuclear cells appeared to be poorly responsive to virus stimulation showing a release of interferon alpha significantly lower than that of the autologous peripheral cells. The interferon alpha release at day 4 by control cells (either intestinal or peripheral) did not differ from that measured after the first 12 hours. In contrast, the interferon alpha produced by Crohn's disease cells progressively increased during the culture period and the amount of interferon alpha measured at day 4 was significantly higher than that released at 12 hours. These data suggest that normal human intestinal mononuclear cells are down regulated in their capability of producing interferon alpha and that in Crohn's disease their activation for this function is enhanced. These data also suggest that in Crohn's disease intestinal mononuclear cells exhibit a transient hyporesponsiveness to in vitro stimulation possibly related to massive in vivo exposure to interferon alpha inducers.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1644329      PMCID: PMC1379401          DOI: 10.1136/gut.33.7.897

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  31 in total

Review 1.  Recent progress in interferon research: molecular mechanisms of regulation, action, and virus circumvention.

Authors:  J L Taylor; S E Grossberg
Journal:  Virus Res       Date:  1990-01       Impact factor: 3.303

2.  A limiting-dilution analysis of activated circulating B cells in Crohn's disease.

Authors:  M Boirivant; F Quintieri; O Pugliese; G Famularo; S Fais; F Pallone
Journal:  J Clin Immunol       Date:  1990-03       Impact factor: 8.317

3.  Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine.

Authors:  T T MacDonald; P Hutchings; M Y Choy; S Murch; A Cooke
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

4.  Monocyte is the main producer of human leukocyte alpha interferons following Sendai virus induction.

Authors:  E Saksela; I Virtanen; T Hovi; D S Secher; K Cantell
Journal:  Prog Med Virol       Date:  1984

5.  Treatment of human peripheral blood leukocytes with proteases does not affect Sendai virus-induced interferon production.

Authors:  K Tsukui; T Miura; E Tokunaga
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

6.  Involvement of the immune system in the pathogenesis of Crohn's disease. Expression of the T9 antigen on peripheral immunocytes correlates with the severity of the disease.

Authors:  A Raedler; S Fraenkel; G Klose; K Seyfarth; H G Thiele
Journal:  Gastroenterology       Date:  1985-04       Impact factor: 22.682

7.  Acid-labile human interferon alpha production by peripheral blood mononuclear cells stimulated by HIV-infected cells.

Authors:  M R Capobianchi; F De Marco; P Di Marco; F Dianzani
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

8.  Interleukin 2 receptor expression by macrophages in inflammatory bowel disease.

Authors:  Y R Mahida; S Patel; K Wu; D P Jewell
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

9.  Human B lymphocytes produce leukocyte interferon after interaction with foreign cells.

Authors:  D A Weigent; M P Langford; E M Smith; J E Blalock; G J Stanton
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

10.  Induction of alpha interferon by membrane interaction between viral surface and peripheral blood mononuclear cells.

Authors:  M R Capobianchi; J Facchini; P Di Marco; G Antonelli; F Dianzani
Journal:  Proc Soc Exp Biol Med       Date:  1985-04
View more
  4 in total

1.  Reconstructing the Molecular Function of Genetic Variation in Regulatory Networks.

Authors:  Roni Wilentzik; Chun Jimmie Ye; Irit Gat-Viks
Journal:  Genetics       Date:  2017-10-18       Impact factor: 4.562

2.  Prospective evaluation of interferon-alpha in treatment of chronic active Crohn's disease.

Authors:  C Gasché; W Reinisch; H Vogelsang; R Pötzi; E Markis; M Micksche; H P Wirth; A Gangl; H Lochs
Journal:  Dig Dis Sci       Date:  1995-04       Impact factor: 3.199

3.  Altered pattern of tumor necrosis factor-alpha production in peripheral blood monocytes from Crohn's disease.

Authors:  Claudia Loganes; Alessia Pin; Samuele Naviglio; Martina Girardelli; Anna Monica Bianco; Stefano Martelossi; Alberto Tommasini; Elisa Piscianz
Journal:  World J Gastroenterol       Date:  2016-11-07       Impact factor: 5.742

4.  Unexpected Discoveries Should Be Reconsidered in Science-A Look to the Past?

Authors:  Alberto Foletti; Stefano Fais
Journal:  Int J Mol Sci       Date:  2019-08-15       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.